MAY 19, 2020 6:30 AM PDT

The Mystery of the Life-Saving Vaccine Solved

WRITTEN BY: Tara Fernandez

 

In the early 1900s, French bacteriologists Albert Calmette and Camille Guérin spent the better half of a decade developing a vaccine that protects infants and young children from succumbing to potentially lethal forms of tuberculosis (TB). Today, this 100-year-old vaccine known as Bacillus Calmette-Guérin, or BCG, is still among the safest and cheapest clinically-available vaccines. 

 

For reasons that have mystified scientists, the BCG vaccine has an added advantage beyond TB-protection. Upon administration, it also prevents newborn deaths from diseases other than TB. In fact, the vaccine slashes the risk of mortality from infections by almost 50 percent. The immunological mechanism behind this, however, has remained a black box.

 

Researchers from the University of British Columbia believe they have found the missing piece to the puzzle: white blood cells called neutrophils. The world’s first study, published in Science Translational Medicine, describes how BCG vaccination triggers a rapid spike in circulating neutrophils, which safeguards the body from invading pathogens.

 

The role that neutrophils play in resisting infection is well understood, but how the BCG vaccine initiates this protective shield was unknown. As senior co-author Nelly Amenyogbe explained, “It was actually thought to be biologically implausible, however we’ve not only shown how BCG is involved, but that it kicks off this process almost instantly following vaccination — far more quickly than anticipated.”

 

With this discovery, the authors believe that making BCG vaccination standard for newborns across the globe could dramatically reduce infant mortality, particularly in low- and middle-income regions.

 

The researchers are currently testing BCG’s potential in protecting individuals against COVID-19. Live attenuated vaccines, such as BCG can trigger a robust systemic immune response which could potentially enhance protection against other pathogenic infections. This hypothesis is being tested in ongoing clinical trials across Australia and the Netherlands.

 


Source: University of British Columbia, Science Translational Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 14, 2020
Immunology
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
JUL 14, 2020
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
Scientists are working on developing an arsenal of nano-sized weapons in the war against COVID-19. These molecules, call ...
JUL 13, 2020
Drug Discovery & Development
Russia Completes First Human Trial for COVID-19 Vaccine
JUL 13, 2020
Russia Completes First Human Trial for COVID-19 Vaccine
The Sechenov University Center for Clinical Research in Moscow, Russia, has completed its first round of clinical trials ...
JUL 19, 2020
Drug Discovery & Development
Study Finds Turmeric has Antiviral Effects
JUL 19, 2020
Study Finds Turmeric has Antiviral Effects
Researchers from the Wuhan University of Engineering in China have found that curcumin, a natural compound found in turm ...
JUL 23, 2020
Immunology
Cancer Therapy Reduces Lung Scarring
JUL 23, 2020
Cancer Therapy Reduces Lung Scarring
Scientists at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have discovered a striking parallel ...
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
Loading Comments...